Search research articles
Contact Us
Filters
Showing results (21-30 of 48) with videos related to
Page
of 5
Sort By:
The Journal of Pharmacology and Experimental Therapeutics
|
January 24, 2009
The role of the equilibrative nucleoside transporter 1 (ENT1) in transport and metabolism of ribavirin by human and wild-type or Ent1-/- mouse erythrocytes
Christopher J Endres, Aaron M Moss, Ban Ke, et al.
Neuroimage
|
October 27, 2009
Imaging serotonergic transmission with [11C]DASB-PET in depressed and non-depressed patients infected with HIV
Dima A Hammoud, Christopher J Endres, Edward Hammond, et al.
Clinical Pharmacology and Therapeutics
|
November 16, 2023
Creation of Novel Sensitive Probe Substrate and Moderate Inhibitor Models for a Comprehensive Prediction of CYP2C8 Interactions for Tucatinib
Ian E Templeton, Karen Rowland-Yeo, Hannah M Jones, et al.
Journal of Clinical Pharmacology
|
May 22, 2014
Population pharmacokinetics of brodalumab in healthy adults and adults with psoriasis from single and multiple dose studies
Christopher J Endres, David H Salinger, Kathleen Köck, et al.
Clinical Pharmacokinetics
|
August 5, 2022
Evaluation of Safety and Clinically Relevant Drug-Drug Interactions with Tucatinib in Healthy Volunteers
Ariel Topletz-Erickson, Anthony Lee, Evelyn L Rustia, et al.
Journal of Neurology
|
December 14, 2011
Decreased microglial activation in MS patients treated with glatiramer acetate
John N Ratchford, Christopher J Endres, Dima A Hammoud, et al.
Lupus
|
July 9, 2016
Neuroimaging of translocator protein in patients with systemic lupus erythematosus: a pilot study using [<sup>11</sup>C]DPA-713 positron emission tomography
Yuchuan Wang, Jennifer M Coughlin, Shuangchao Ma, et al.
Clinical Pharmacokinetics
|
January 19, 2011
Quantitative prediction of human pharmacokinetics for monoclonal antibodies: retrospective analysis of monkey as a single species for first-in-human prediction
Jennifer Q Dong, David H Salinger, Christopher J Endres, et al.
Neuroimage
|
August 22, 2006
An extended simplified reference tissue model for the quantification of dynamic PET with amphetamine challenge
Yun Zhou, Ming-Kai Chen, Christopher J Endres, et al.
Clinical Pharmacokinetics
|
December 5, 2022
The Pharmacokinetics and Safety of Tucatinib in Volunteers with Hepatic Impairment
Ariel R Topletz-Erickson, Anthony J Lee, JoAl G Mayor, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 48) with videos related to
Sort By:
Page
of 5
The Journal of Pharmacology and Experimental Therapeutics
|
January 24, 2009
The role of the equilibrative nucleoside transporter 1 (ENT1) in transport and metabolism of ribavirin by human and wild-type or Ent1-/- mouse erythrocytes
Christopher J Endres, Aaron M Moss, Ban Ke, et al.
Neuroimage
|
October 27, 2009
Imaging serotonergic transmission with [11C]DASB-PET in depressed and non-depressed patients infected with HIV
Dima A Hammoud, Christopher J Endres, Edward Hammond, et al.
Clinical Pharmacology and Therapeutics
|
November 16, 2023
Creation of Novel Sensitive Probe Substrate and Moderate Inhibitor Models for a Comprehensive Prediction of CYP2C8 Interactions for Tucatinib
Ian E Templeton, Karen Rowland-Yeo, Hannah M Jones, et al.
Journal of Clinical Pharmacology
|
May 22, 2014
Population pharmacokinetics of brodalumab in healthy adults and adults with psoriasis from single and multiple dose studies
Christopher J Endres, David H Salinger, Kathleen Köck, et al.
Clinical Pharmacokinetics
|
August 5, 2022
Evaluation of Safety and Clinically Relevant Drug-Drug Interactions with Tucatinib in Healthy Volunteers
Ariel Topletz-Erickson, Anthony Lee, Evelyn L Rustia, et al.
Journal of Neurology
|
December 14, 2011
Decreased microglial activation in MS patients treated with glatiramer acetate
John N Ratchford, Christopher J Endres, Dima A Hammoud, et al.
Lupus
|
July 9, 2016
Neuroimaging of translocator protein in patients with systemic lupus erythematosus: a pilot study using [<sup>11</sup>C]DPA-713 positron emission tomography
Yuchuan Wang, Jennifer M Coughlin, Shuangchao Ma, et al.
Clinical Pharmacokinetics
|
January 19, 2011
Quantitative prediction of human pharmacokinetics for monoclonal antibodies: retrospective analysis of monkey as a single species for first-in-human prediction
Jennifer Q Dong, David H Salinger, Christopher J Endres, et al.
Neuroimage
|
August 22, 2006
An extended simplified reference tissue model for the quantification of dynamic PET with amphetamine challenge
Yun Zhou, Ming-Kai Chen, Christopher J Endres, et al.
Clinical Pharmacokinetics
|
December 5, 2022
The Pharmacokinetics and Safety of Tucatinib in Volunteers with Hepatic Impairment
Ariel R Topletz-Erickson, Anthony J Lee, JoAl G Mayor, et al.
Page
of 5